Serveur d'exploration sur la COVID chez les séniors

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.

Identifieur interne : 000326 ( Main/Exploration ); précédent : 000325; suivant : 000327

Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.

Auteurs : Laura L. Blaisdell ; Wendy Cohn ; Jeff R. Pavell ; Dana S. Rubin ; Jeffrey E. Vergales

Source :

RBID : pubmed:32881850

Descripteurs français

English descriptors

Abstract

The World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020.* Shortly thereafter, closures of 124,000 U.S. public and private schools affected at least 55.1 million students through the end of the 2019-20 school year. During the summer of 2020, approximately 82% of 8,947 U.S. overnight camps did not operate.§ In Maine, only approximately 20% of 100 overnight camps opened. An overnight camp in Georgia recently reported SARS-CoV-2, the virus that causes COVID-19, transmission among campers and staff members when nonpharmaceutical interventions (NPIs) were not strictly followed (1); however, NPIs have been successfully used to mitigate SARS-CoV-2 transmission among military basic trainees (2). During June-August 2020, four overnight camps in Maine implemented several NPIs to prevent and mitigate the transmission of SARS-CoV-2, including prearrival quarantine, pre- and postarrival testing and symptom screening, cohorting, use of face coverings, physical distancing, enhanced hygiene measures, cleaning and disinfecting, and maximal outdoor programming. During the camp sessions, testing and symptom screening enabled early and rapid identification and isolation of attendees with COVID-19. Among the 1,022 attendees (staff members and campers) from 41 states, one territory, and six international locations, 1,010 were tested before arrival; 12 attendees who had completed a period of isolation after receiving a diagnosis of COVID-19 2 months before arrival were not tested. Four (0.4%) asymptomatic attendees received positive SARS-CoV-2 test results before arrival; these persons delayed their arrival, completed 10 days of isolation at home, remained asymptomatic, and did not receive any further testing before arrival or for the duration of camp attendance. Approximately 1 week after camp arrival, all 1,006 attendees without a previous diagnosis of COVID-19 were tested, and three asymptomatic cases were identified. Following isolation of these persons and quarantine of their contacts, no secondary transmission of SARS-CoV-2 occurred. These findings can inform similar multilayered public health strategies to prevent and mitigate the introduction and transmission of SARS-CoV-2 among children, adolescents, and adults in congregate settings, such as overnight camps, residential schools, and colleges.

DOI: 10.15585/mmwr.mm6935e1
PubMed: 32881850
PubMed Central: PMC7470465


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.</title>
<author>
<name sortKey="Blaisdell, Laura L" sort="Blaisdell, Laura L" uniqKey="Blaisdell L" first="Laura L" last="Blaisdell">Laura L. Blaisdell</name>
</author>
<author>
<name sortKey="Cohn, Wendy" sort="Cohn, Wendy" uniqKey="Cohn W" first="Wendy" last="Cohn">Wendy Cohn</name>
</author>
<author>
<name sortKey="Pavell, Jeff R" sort="Pavell, Jeff R" uniqKey="Pavell J" first="Jeff R" last="Pavell">Jeff R. Pavell</name>
</author>
<author>
<name sortKey="Rubin, Dana S" sort="Rubin, Dana S" uniqKey="Rubin D" first="Dana S" last="Rubin">Dana S. Rubin</name>
</author>
<author>
<name sortKey="Vergales, Jeffrey E" sort="Vergales, Jeffrey E" uniqKey="Vergales J" first="Jeffrey E" last="Vergales">Jeffrey E. Vergales</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32881850</idno>
<idno type="pmid">32881850</idno>
<idno type="doi">10.15585/mmwr.mm6935e1</idno>
<idno type="pmc">PMC7470465</idno>
<idno type="wicri:Area/Main/Corpus">000362</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000362</idno>
<idno type="wicri:Area/Main/Curation">000362</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000362</idno>
<idno type="wicri:Area/Main/Exploration">000362</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.</title>
<author>
<name sortKey="Blaisdell, Laura L" sort="Blaisdell, Laura L" uniqKey="Blaisdell L" first="Laura L" last="Blaisdell">Laura L. Blaisdell</name>
</author>
<author>
<name sortKey="Cohn, Wendy" sort="Cohn, Wendy" uniqKey="Cohn W" first="Wendy" last="Cohn">Wendy Cohn</name>
</author>
<author>
<name sortKey="Pavell, Jeff R" sort="Pavell, Jeff R" uniqKey="Pavell J" first="Jeff R" last="Pavell">Jeff R. Pavell</name>
</author>
<author>
<name sortKey="Rubin, Dana S" sort="Rubin, Dana S" uniqKey="Rubin D" first="Dana S" last="Rubin">Dana S. Rubin</name>
</author>
<author>
<name sortKey="Vergales, Jeffrey E" sort="Vergales, Jeffrey E" uniqKey="Vergales J" first="Jeffrey E" last="Vergales">Jeffrey E. Vergales</name>
</author>
</analytic>
<series>
<title level="j">MMWR. Morbidity and mortality weekly report</title>
<idno type="eISSN">1545-861X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Asymptomatic Diseases (MeSH)</term>
<term>Camping (MeSH)</term>
<term>Child (MeSH)</term>
<term>Clinical Laboratory Techniques (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Maine (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Quarantine (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Camping (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Jeune adulte (MeSH)</term>
<term>Maine (épidémiologie)</term>
<term>Maladies asymptomatiques (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Quarantaine (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Techniques de laboratoire clinique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Maine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Maine</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Asymptomatic Diseases</term>
<term>Camping</term>
<term>Child</term>
<term>Clinical Laboratory Techniques</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Quarantine</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Camping</term>
<term>Enfant</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Maladies asymptomatiques</term>
<term>Mâle</term>
<term>Quarantaine</term>
<term>Sujet âgé</term>
<term>Techniques de laboratoire clinique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020.* Shortly thereafter, closures of 124,000 U.S. public and private schools affected at least 55.1 million students through the end of the 2019-20 school year.
<sup></sup>
During the summer of 2020, approximately 82% of 8,947 U.S. overnight camps did not operate.
<sup>§</sup>
In Maine, only approximately 20% of 100 overnight camps opened.
<sup></sup>
An overnight camp in Georgia recently reported SARS-CoV-2, the virus that causes COVID-19, transmission among campers and staff members when nonpharmaceutical interventions (NPIs) were not strictly followed (1); however, NPIs have been successfully used to mitigate SARS-CoV-2 transmission among military basic trainees (2). During June-August 2020, four overnight camps in Maine implemented several NPIs to prevent and mitigate the transmission of SARS-CoV-2, including prearrival quarantine, pre- and postarrival testing and symptom screening, cohorting, use of face coverings, physical distancing, enhanced hygiene measures, cleaning and disinfecting, and maximal outdoor programming. During the camp sessions, testing and symptom screening enabled early and rapid identification and isolation of attendees with COVID-19. Among the 1,022 attendees (staff members and campers) from 41 states, one territory, and six international locations, 1,010 were tested before arrival; 12 attendees who had completed a period of isolation after receiving a diagnosis of COVID-19 2 months before arrival were not tested. Four (0.4%) asymptomatic attendees received positive SARS-CoV-2 test results before arrival; these persons delayed their arrival, completed 10 days of isolation at home, remained asymptomatic, and did not receive any further testing before arrival or for the duration of camp attendance. Approximately 1 week after camp arrival, all 1,006 attendees without a previous diagnosis of COVID-19 were tested, and three asymptomatic cases were identified. Following isolation of these persons and quarantine of their contacts, no secondary transmission of SARS-CoV-2 occurred. These findings can inform similar multilayered public health strategies to prevent and mitigate the introduction and transmission of SARS-CoV-2 among children, adolescents, and adults in congregate settings, such as overnight camps, residential schools, and colleges.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32881850</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1545-861X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>69</Volume>
<Issue>35</Issue>
<PubDate>
<Year>2020</Year>
<Month>Sep</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>MMWR. Morbidity and mortality weekly report</Title>
<ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.</ArticleTitle>
<Pagination>
<MedlinePgn>1216-1220</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm6935e1</ELocationID>
<Abstract>
<AbstractText>The World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020.* Shortly thereafter, closures of 124,000 U.S. public and private schools affected at least 55.1 million students through the end of the 2019-20 school year.
<sup></sup>
During the summer of 2020, approximately 82% of 8,947 U.S. overnight camps did not operate.
<sup>§</sup>
In Maine, only approximately 20% of 100 overnight camps opened.
<sup></sup>
An overnight camp in Georgia recently reported SARS-CoV-2, the virus that causes COVID-19, transmission among campers and staff members when nonpharmaceutical interventions (NPIs) were not strictly followed (1); however, NPIs have been successfully used to mitigate SARS-CoV-2 transmission among military basic trainees (2). During June-August 2020, four overnight camps in Maine implemented several NPIs to prevent and mitigate the transmission of SARS-CoV-2, including prearrival quarantine, pre- and postarrival testing and symptom screening, cohorting, use of face coverings, physical distancing, enhanced hygiene measures, cleaning and disinfecting, and maximal outdoor programming. During the camp sessions, testing and symptom screening enabled early and rapid identification and isolation of attendees with COVID-19. Among the 1,022 attendees (staff members and campers) from 41 states, one territory, and six international locations, 1,010 were tested before arrival; 12 attendees who had completed a period of isolation after receiving a diagnosis of COVID-19 2 months before arrival were not tested. Four (0.4%) asymptomatic attendees received positive SARS-CoV-2 test results before arrival; these persons delayed their arrival, completed 10 days of isolation at home, remained asymptomatic, and did not receive any further testing before arrival or for the duration of camp attendance. Approximately 1 week after camp arrival, all 1,006 attendees without a previous diagnosis of COVID-19 were tested, and three asymptomatic cases were identified. Following isolation of these persons and quarantine of their contacts, no secondary transmission of SARS-CoV-2 occurred. These findings can inform similar multilayered public health strategies to prevent and mitigate the introduction and transmission of SARS-CoV-2 among children, adolescents, and adults in congregate settings, such as overnight camps, residential schools, and colleges.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Blaisdell</LastName>
<ForeName>Laura L</ForeName>
<Initials>LL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cohn</LastName>
<ForeName>Wendy</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pavell</LastName>
<ForeName>Jeff R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rubin</LastName>
<ForeName>Dana S</ForeName>
<Initials>DS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vergales</LastName>
<ForeName>Jeffrey E</ForeName>
<Initials>JE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>09</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA>
<NlmUniqueID>7802429</NlmUniqueID>
<ISSNLinking>0149-2195</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000657964">COVID-19 diagnostic testing</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002165" MajorTopicYN="Y">Camping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008281" MajorTopicYN="N" Type="Geographic">Maine</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Dana S. Rubin reports professional fees for services as the camp doctor. Laura L. Blaisdell reports she is the medical director of a camp that is owned and operated by her spouse. No other potential conflicts of interest were disclosed.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32881850</ArticleId>
<ArticleId IdType="doi">10.15585/mmwr.mm6935e1</ArticleId>
<ArticleId IdType="pmc">PMC7470465</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>EClinicalMedicine. 2020 Jun 26;24:100433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32766542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Pediatr. 2020 Jul 03;8:431</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32719759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Paediatr. 2020 Jun;109(6):1088-1095</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32202343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2006 Jan;12(1):81-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32759921</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2012 Jun;31(6):547-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22414902</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2020 Jun 05;69(22):685-688</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32497031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Biomed. 2020 May 11;91(2):172-176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32420941</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2007 Aug 8;298(6):644-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17684187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Blaisdell, Laura L" sort="Blaisdell, Laura L" uniqKey="Blaisdell L" first="Laura L" last="Blaisdell">Laura L. Blaisdell</name>
<name sortKey="Cohn, Wendy" sort="Cohn, Wendy" uniqKey="Cohn W" first="Wendy" last="Cohn">Wendy Cohn</name>
<name sortKey="Pavell, Jeff R" sort="Pavell, Jeff R" uniqKey="Pavell J" first="Jeff R" last="Pavell">Jeff R. Pavell</name>
<name sortKey="Rubin, Dana S" sort="Rubin, Dana S" uniqKey="Rubin D" first="Dana S" last="Rubin">Dana S. Rubin</name>
<name sortKey="Vergales, Jeffrey E" sort="Vergales, Jeffrey E" uniqKey="Vergales J" first="Jeffrey E" last="Vergales">Jeffrey E. Vergales</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000326 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000326 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidSeniorV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32881850
   |texte=   Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32881850" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidSeniorV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021